If this succeeds the basis for 10X to continue to operate is critically hampered, as it may impede their ability to sell both their Chromium device and kits. On the other side, 10X currently is ...

Million-Cell Experiments Routinely Accessible for the First TimePLEASANTON, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Building on its industry leading position in single cell analysis, 10x ...

PLEASANTON, Calif., Sept. 3, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Chromium Xo, a new addition to its ...

The next generation of the company's leading single cell technology architecture, GEM-X, enables higher performance at larger scale and lower cost PLEASANTON, Calif., March 13, 2024 /PRNewswire/ -- ...

10x Genomics (TXG) said it has begun shipping the first two products powered by its next-generation GEM-X technology architecture. Read more here.

On November 20, 2019, the Munich District Court in Germany ruled that 10X’s GEM microfluidic chips, as well as certain Chromium instruments and related accessories, infringed a German utility ...

Ben Hindson, chief scientific officer, co-founder, president of 10x Genomics, announces the launch of the next generation of the company’s single-cell technology architecture that will power new ...

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Chromium Xo, a new addition to its fleet of Chromium single cell instruments. Designed to ...